13F-HR filed by Avidity Partners Management LP
Avidity Partners Management LP filed this 13F-HR for the quarter ended 2023-12-31, filed 2024-02-14, with 74 holding rows worth $2,743,946,962.
- Accession
- 0001791827-24-000002
- Filer
- CIK 1791827
- Filed
- 2024-02-14
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q4 2023
A holdings report, 74 entries on the cover page, a total value of $2,743,946,962 stated on the cover page (in dollars after the unit check, H1), rows summing to $2,743,946,962 with VALUE read as dollars as filed, 13F file number 028-20028. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| ARVINAS INC | 04335A105 | COM | 2,985,117 | $122,867,416 | dollars as filed | |
| Boston Scientific Corporation | 101137107 | COM | 1,890,000 | $109,260,900 | dollars as filed | |
| Cigna Corporation | 125523100 | COM | 350,000 | $104,807,500 | dollars as filed | call |
| Thermo Fisher Scientific Inc. | 883556102 | COM | 182,600 | $96,922,254 | dollars as filed | |
| ACADIA HEALTHCARE COMPANY INC COM | 00404A109 | Stock | 1,156,692 | $89,944,370 | dollars as filed | |
| NEUROCRINE BIOSCIENCES INC | 64125C109 | COM | 658,000 | $86,698,080 | dollars as filed | |
| SYNDAX PHARMACEUTICALS INC | 87164F105 | COM | 3,950,000 | $85,359,500 | dollars as filed | |
| NATERA INC COM | 632307104 | Stock | 1,110,000 | $69,530,400 | dollars as filed | |
| Danaher Corporation | 235851102 | COM | 290,000 | $67,088,600 | dollars as filed | |
| TENET HEALTHCARE CORP COM NEW | 88033G407 | Stock | 871,000 | $65,821,470 | dollars as filed | |
| KARUNA THERAPEUTICS INC | 48576A100 | COM | 206,000 | $65,201,060 | dollars as filed | |
| FUSION PHARMACEUTICALS INC | 36118A100 | COM | 6,500,328 | $62,468,152 | dollars as filed | |
| JAZZ PHARMACEUTICALS PLC SHS USD | G50871105 | Stock | 489,119 | $60,161,637 | dollars as filed | |
| REGENERON PHARMACEUTICALS COM | 75886F107 | Stock | 68,000 | $59,723,720 | dollars as filed | |
| CVS Health Corporation | 126650100 | COM | 740,000 | $58,430,400 | dollars as filed | |
| BLUEPRINT MEDICINES CORP | 09627Y109 | COM | 615,000 | $56,727,600 | dollars as filed | |
| IMMUNOGEN INC | 45253H101 | COMMON STOCK | 1,829,215 | $54,236,225 | dollars as filed | |
| IDEAYA BIOSCIENCES INC COM | 45166A102 | Stock | 1,520,000 | $54,081,600 | dollars as filed | |
| UNITED THERAPEUTICS CORP DEL COM | 91307C102 | Stock | 237,202 | $52,158,348 | dollars as filed | |
| ROCKET PHARMACEUTICALS INC | 77313F106 | COM | 1,719,103 | $51,521,517 | dollars as filed | |
| INTRA-CELLULAR THERAPIES INC | 46116X101 | COMMON STOCK | 710,000 | $50,850,200 | dollars as filed | |
| Eli Lilly and Company | 532457108 | COM | 85,000 | $49,548,200 | dollars as filed | |
| BIOHAVEN LTD | G1110E107 | COM | 1,148,308 | $49,147,582 | dollars as filed | |
| AVANTOR INC COM | 05352A100 | Stock | 2,121,844 | $48,441,699 | dollars as filed | |
| ZOETIS INC CL A | 98978V103 | Stock | 240,000 | $47,368,800 | dollars as filed | |
| HUMANA INC COM | 444859102 | Stock | 100,000 | $45,781,000 | dollars as filed | |
| AbbVie,Inc. | 00287Y109 | COM | 284,405 | $44,074,243 | dollars as filed | |
| STRUCTURE THERAPEUTICS INC COMP | 86366E106 | EQUITY | 1,080,000 | $44,020,800 | dollars as filed | |
| ALIGN TECHNOLOGY INC COM | 016255101 | Stock | 155,800 | $42,689,200 | dollars as filed | |
| LEGEND BIOTECH CORP | 52490G102 | SPONSORED ADS | 685,000 | $41,216,450 | dollars as filed | |
| BECTON DICKINSON & CO | 075887109 | COM | 165,706 | $40,404,094 | dollars as filed | |
| ULTRAGENYX PHARMACEUTICAL IN | 90400D108 | COM | 844,500 | $40,383,990 | dollars as filed | |
| MCKESSON CORP COM | 58155Q103 | Stock | 85,500 | $39,584,790 | dollars as filed | |
| XENON PHARMACEUTICALS INC COM | 98420N105 | Stock | 815,993 | $37,584,638 | dollars as filed | |
| SURGERY PARTNERS INC | 86881A100 | COM | 1,165,932 | $37,298,165 | dollars as filed | |
| AXSOME THERAPEUTICS INC. COM | 05464T104 | Stock | 459,400 | $36,563,646 | dollars as filed | |
| CARIBOU BIOSCIENCES INC COM | 142038108 | Stock | 6,360,212 | $36,444,015 | dollars as filed | |
| VAXCYTE INC COM | 92243G108 | Stock | 570,137 | $35,804,604 | dollars as filed | |
| NEUMORA THERAPEUTICS INC. | 640979100 | COM | 1,990,632 | $33,940,276 | dollars as filed | |
| MIRUM PHARMACEUTICALS INC | 604749101 | COM | 1,142,850 | $33,736,932 | dollars as filed | |
| UnitedHealth Group Inc | 91324P102 | COM | 58,500 | $30,798,495 | dollars as filed | |
| PRIVIA HEALTH GROUP INC | 74276R102 | COM | 1,287,000 | $29,639,610 | dollars as filed | |
| Intuitive Surgical,Inc. | 46120E602 | COM | 85,000 | $28,675,600 | dollars as filed | |
| STRUCTURE THERAPEUTICS INC COMP | 86366E106 | EQUITY | 600,000 | $24,456,000 | dollars as filed | call |
| LANTHEUS HLDGS INC | 516544103 | COM | 380,000 | $23,560,000 | dollars as filed | |
| AN2 THERAPEUTICS INC | 037326105 | COM | 1,140,000 | $23,358,600 | dollars as filed | |
| AC IMMUNE SA | H00263105 | SHS | 4,469,080 | $22,345,400 | dollars as filed | |
| ARROWHEAD PHARMACEUTICALS IN | 04280A100 | COM | 714,000 | $21,848,400 | dollars as filed | |
| IMMUNOCORE HLDGS PLC ADS | 45258D105 | ADR | 300,200 | $20,509,664 | dollars as filed | |
| CRINETICS PHARMACEUTICALS INC COM | 22663K107 | Stock | 529,000 | $18,821,820 | dollars as filed | |
| PHATHOM PHARMACEUTICALS INC | 71722W107 | COMMON STOCK | 1,721,580 | $15,718,025 | dollars as filed | |
| VERONA PHARMA PLC | 925050106 | SPONSORED ADS | 780,900 | $15,524,292 | dollars as filed | |
| IMMUNOME INC | 45257U108 | COM | 1,333,479 | $14,268,225 | dollars as filed | |
| AGILENT TECHNOLOGIES INC COM | 00846U101 | Stock | 99,000 | $13,763,970 | dollars as filed | |
| INTELLIA THERAPEUTICS INC | 45826J105 | COM | 447,434 | $13,642,263 | dollars as filed | |
| SYROS PHARMACEUTICALS INC | 87184Q206 | COM NEW | 1,673,538 | $13,036,861 | dollars as filed | |
| DIANTHUS THERAPEUTICS INC | 252828108 | COM | 1,217,554 | $12,662,562 | dollars as filed | |
| ARGENX SE SPONSORED ADR | 04016X101 | ADR | 31,000 | $11,793,330 | dollars as filed | |
| CEREVEL THERAPEUTICS HLDNG I | 15678U128 | COM | 276,888 | $11,740,051 | dollars as filed | |
| COLLEGIUM PHARMACEUTICAL INC | 19459J104 | COM | 361,363 | $11,122,753 | dollars as filed | |
| IMMUNOVANT INC | 45258J102 | COM | 245,000 | $10,321,850 | dollars as filed | |
| NEUROGENE INC | 64135M105 | COMMON STOCK | 466,243 | $9,035,789 | dollars as filed | |
| TRAVERE THERAPEUTICS INC | 89422G107 | COM | 827,010 | $7,434,820 | dollars as filed | |
| KARYOPHARM THERAPEUTICS INC | 48576U106 | COM | 8,298,570 | $7,178,263 | dollars as filed | |
| AKERO THERAPEUTICS INC | 00973Y108 | COM | 235,000 | $5,487,250 | dollars as filed | |
| KEZAR LIFE SCIENCES INC | 49372L100 | COM | 5,025,454 | $4,761,115 | dollars as filed | |
| CENTURY THERAPEUTICS INC | 15673T100 | COM | 1,355,000 | $4,498,600 | dollars as filed | |
| SCYNEXIS INC | 811292200 | COM NEW | 1,448,728 | $3,230,663 | dollars as filed | |
| COMPASS THERAPEUTICS INC | 20454B104 | COM | 1,599,600 | $2,495,376 | dollars as filed | |
| REVOLUTION MEDICINES INC COM | 76155X100 | Stock | 60,000 | $1,720,800 | dollars as filed | |
| HYPERFINE INC | 44916K106 | Common Stock | 1,188,178 | $1,330,759 | dollars as filed | |
| AMYLYX PHARMACEUTICALS INC | 03237H101 | COM | 64,501 | $949,455 | dollars as filed | |
| CAREMAX INC | 14171W103 | COM | 636,000 | $316,855 | dollars as filed | |
| NUVATION BIO INC | 67080N119 | WARR | 89,543 | $5,373 | dollars as filed |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001791827-24-000002 | this filing | 2024-02-14 | acceptance time not in the bulk data set |